Botox superior to topiramate for relieving migraine

Andrew M. Blumenfeld
SAN FRANCISCO — Significantly more patients treated with Botox had a 50% reduction in headache days than those treated with topiramate, according to a presentation at the American Headache Society Annual Scientific Meeting.
Published data has shown that topiramate is less effective for reducing headache days among patients with chronic migraine than Botox (onabotulinumtoxinA, Allergan), Andrew M. Blumenfeld, MD, from the Headache Center of Southern California, said during the presentation.
“Yet in clinical practice, topiramate tends to be a first-line preventive
Back to top button